256 related articles for article (PubMed ID: 16034483)
1. The involvement of glutamate in the pathophysiology of depression.
Palucha A; Pilc A
Drug News Perspect; 2005 May; 18(4):262-8. PubMed ID: 16034483
[TBL] [Abstract][Full Text] [Related]
2. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
Pałucha A; Pilc A
Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
4. Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation.
Oliveira JF; Krügel U; Köles L; Illes P; Wirkner K
Neuropharmacology; 2008 Sep; 55(4):447-53. PubMed ID: 18680754
[TBL] [Abstract][Full Text] [Related]
5. Modulation of low-frequency-induced synaptic depression in the developing CA3-CA1 hippocampal synapses by NMDA and metabotropic glutamate receptor activation.
Strandberg J; Wasling P; Gustafsson B
J Neurophysiol; 2009 May; 101(5):2252-62. PubMed ID: 19225168
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice.
Kos T; Legutko B; Danysz W; Samoriski G; Popik P
J Pharmacol Exp Ther; 2006 Sep; 318(3):1128-36. PubMed ID: 16740621
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor 1 activity generates persistent, N-methyl-D-aspartate receptor-dependent depression of hippocampal pyramidal cell excitability.
Clement JP; Randall AD; Brown JT
Eur J Neurosci; 2009 Jun; 29(12):2347-62. PubMed ID: 19490024
[TBL] [Abstract][Full Text] [Related]
8. NMDA and group I metabotropic glutamate receptors activation modulates substance P release from the arcuate nucleus and median eminence.
Caruso C; Durand D; Watanobe H; Lasaga M
Neurosci Lett; 2006 Jan; 393(1):60-4. PubMed ID: 16226374
[TBL] [Abstract][Full Text] [Related]
9. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
Chaki S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
[TBL] [Abstract][Full Text] [Related]
10. The role of glutamate on the action of antidepressants.
Hashimoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
[TBL] [Abstract][Full Text] [Related]
11. A role for AMPA receptors in mood disorders.
Alt A; Nisenbaum ES; Bleakman D; Witkin JM
Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080
[TBL] [Abstract][Full Text] [Related]
12. Role of metabotropic glutamate receptors in animal models of Parkinson's disease.
Senkowska A; Ossowska K
Pol J Pharmacol; 2003; 55(6):935-50. PubMed ID: 14730087
[TBL] [Abstract][Full Text] [Related]
13. Glutamate-based antidepressants: preclinical psychopharmacology.
Pilc A; Wierońska JM; Skolnick P
Biol Psychiatry; 2013 Jun; 73(12):1125-32. PubMed ID: 23453290
[TBL] [Abstract][Full Text] [Related]
14. Role of metabotropic glutamate receptors in the control of neuroendocrine function.
Durand D; Pampillo M; Caruso C; Lasaga M
Neuropharmacology; 2008 Sep; 55(4):577-83. PubMed ID: 18616955
[TBL] [Abstract][Full Text] [Related]
15. Glutamate-based antidepressants: 20 years on.
Skolnick P; Popik P; Trullas R
Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptors modulate the NMDA- and AMPA-induced gene expression in neocortical interneurons.
Lindemeyer K; Leemhuis J; Löffler S; Grass N; Nörenberg W; Meyer DK
Cereb Cortex; 2006 Nov; 16(11):1662-77. PubMed ID: 16407481
[TBL] [Abstract][Full Text] [Related]
17. [Antagonists of ionotropic glutamate receptors as the object of research in psychopharmacology].
Bespalov AIu; Evartau EE
Usp Fiziol Nauk; 1999; 30(1):39-53. PubMed ID: 10205818
[TBL] [Abstract][Full Text] [Related]
18. [Modern aspects of investigation and clinical application of glutamatergic agents].
Petrov VI; Onishchenko NV
Eksp Klin Farmakol; 2002; 65(4):66-70. PubMed ID: 12449079
[TBL] [Abstract][Full Text] [Related]
19. The possible involvement of metabotropic glutamate receptors in schizophrenia.
Krivoy A; Fischel T; Weizman A
Eur Neuropsychopharmacol; 2008 Jun; 18(6):395-405. PubMed ID: 18063347
[TBL] [Abstract][Full Text] [Related]
20. Glutamate as a therapeutic target in psychiatric disorders.
Javitt DC
Mol Psychiatry; 2004 Nov; 9(11):984-97, 979. PubMed ID: 15278097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
